DK1607399T3 - Bis-(N,N'-bis-(2-halogenethyl)-amino)-phosphoramidater som antitumormidler - Google Patents

Bis-(N,N'-bis-(2-halogenethyl)-amino)-phosphoramidater som antitumormidler

Info

Publication number
DK1607399T3
DK1607399T3 DK05020467.6T DK05020467T DK1607399T3 DK 1607399 T3 DK1607399 T3 DK 1607399T3 DK 05020467 T DK05020467 T DK 05020467T DK 1607399 T3 DK1607399 T3 DK 1607399T3
Authority
DK
Denmark
Prior art keywords
bis
haloethyl
phosphoramidates
amino
antitumor agents
Prior art date
Application number
DK05020467.6T
Other languages
Danish (da)
English (en)
Inventor
Jason R Herr
Robert T Lum
Michael R Kozlowski
Steven R Schow
Pavel Zhichkin
Fanying Meng
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik Inc filed Critical Telik Inc
Application granted granted Critical
Publication of DK1607399T3 publication Critical patent/DK1607399T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2404—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2408—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of hydroxyalkyl compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK05020467.6T 2000-05-02 2001-05-02 Bis-(N,N'-bis-(2-halogenethyl)-amino)-phosphoramidater som antitumormidler DK1607399T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56318100A 2000-05-02 2000-05-02
EP01935025A EP1278759B1 (en) 2000-05-02 2001-05-02 Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents

Publications (1)

Publication Number Publication Date
DK1607399T3 true DK1607399T3 (da) 2010-05-10

Family

ID=24249433

Family Applications (2)

Application Number Title Priority Date Filing Date
DK05020467.6T DK1607399T3 (da) 2000-05-02 2001-05-02 Bis-(N,N'-bis-(2-halogenethyl)-amino)-phosphoramidater som antitumormidler
DK01935025T DK1278759T3 (da) 2000-05-02 2001-05-02 Bis-(N,N'-bis-(2-halogenethyl)amino)phoshoramidater som antitumormidler

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK01935025T DK1278759T3 (da) 2000-05-02 2001-05-02 Bis-(N,N'-bis-(2-halogenethyl)amino)phoshoramidater som antitumormidler

Country Status (25)

Country Link
EP (2) EP1278759B1 (cg-RX-API-DMAC10.html)
JP (1) JP4249928B2 (cg-RX-API-DMAC10.html)
KR (1) KR100729980B1 (cg-RX-API-DMAC10.html)
CN (1) CN1182143C (cg-RX-API-DMAC10.html)
AR (1) AR029072A1 (cg-RX-API-DMAC10.html)
AT (2) ATE313549T1 (cg-RX-API-DMAC10.html)
AU (2) AU6115301A (cg-RX-API-DMAC10.html)
BR (1) BR0110553A (cg-RX-API-DMAC10.html)
CA (1) CA2407606C (cg-RX-API-DMAC10.html)
CZ (1) CZ20023615A3 (cg-RX-API-DMAC10.html)
DE (2) DE60116081T2 (cg-RX-API-DMAC10.html)
DK (2) DK1607399T3 (cg-RX-API-DMAC10.html)
EA (1) EA006852B1 (cg-RX-API-DMAC10.html)
ES (2) ES2337154T3 (cg-RX-API-DMAC10.html)
HU (1) HUP0300688A3 (cg-RX-API-DMAC10.html)
IL (2) IL152325A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA02010813A (cg-RX-API-DMAC10.html)
NO (2) NO328854B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ522189A (cg-RX-API-DMAC10.html)
PL (1) PL207005B1 (cg-RX-API-DMAC10.html)
PT (1) PT1607399E (cg-RX-API-DMAC10.html)
TW (1) TWI308569B (cg-RX-API-DMAC10.html)
UA (1) UA74574C2 (cg-RX-API-DMAC10.html)
WO (1) WO2001083496A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200208591B (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200600091A (en) 2004-05-21 2006-01-01 Telik Inc Sulfonylethyl phosphorodiamidates
US8198247B2 (en) 2004-12-21 2012-06-12 Telik, Inc. Process for and intermediates in the preparation of canfosfamide and its salts
US7655799B2 (en) 2006-11-29 2010-02-02 Telik, Inc. 2{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidates
US7872134B2 (en) 2007-12-12 2011-01-18 Telik, Inc. 2-{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N-bis(2-chloroethyl)phosphorodiamidates
US9879267B2 (en) * 2008-03-14 2018-01-30 Genentech, Inc. Genetic variations associated with drug resistance
CN118834240A (zh) 2019-05-13 2024-10-25 深圳艾欣达伟医药科技有限公司 含氟化合物及抗癌医药用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556942A (en) * 1991-04-29 1996-09-17 Terrapin Technologies, Inc. Glutathione S-transferase-activated compounds

Also Published As

Publication number Publication date
CA2407606C (en) 2008-07-15
DE60116081D1 (en) 2006-01-26
HUP0300688A3 (en) 2005-02-28
DK1278759T3 (da) 2006-02-13
ZA200208591B (en) 2004-03-04
JP4249928B2 (ja) 2009-04-08
NO331833B1 (no) 2012-04-16
EP1607399A3 (en) 2006-01-04
CN1182143C (zh) 2004-12-29
EP1607399B1 (en) 2010-01-20
PL207005B1 (pl) 2010-10-29
PT1607399E (pt) 2010-02-02
AR029072A1 (es) 2003-06-04
PL358155A1 (en) 2004-08-09
HK1050368A1 (en) 2003-06-20
EA006852B1 (ru) 2006-04-28
NO20025240L (no) 2002-12-04
AU6115301A (en) 2001-11-12
HK1084119A1 (en) 2006-07-21
NO20025240D0 (no) 2002-11-01
HUP0300688A2 (hu) 2003-07-28
WO2001083496A1 (en) 2001-11-08
DE60116081T2 (de) 2006-08-03
NO20093371L (no) 2002-12-04
IL152325A (en) 2011-04-28
KR100729980B1 (ko) 2007-06-20
CA2407606A1 (en) 2001-11-08
IL152325A0 (en) 2003-05-29
NZ522189A (en) 2004-04-30
ATE455779T1 (de) 2010-02-15
ES2253380T3 (es) 2006-06-01
AU2001261153B2 (en) 2005-04-07
MXPA02010813A (es) 2004-02-26
BR0110553A (pt) 2003-04-01
EP1607399A2 (en) 2005-12-21
ES2337154T3 (es) 2010-04-21
JP2003531913A (ja) 2003-10-28
EP1278759A1 (en) 2003-01-29
TWI308569B (en) 2009-04-11
UA74574C2 (en) 2006-01-16
ATE313549T1 (de) 2006-01-15
KR20020094000A (ko) 2002-12-16
CN1427844A (zh) 2003-07-02
NO328854B1 (no) 2010-05-31
EA200201154A1 (ru) 2003-04-24
CZ20023615A3 (cs) 2003-04-16
EP1278759B1 (en) 2005-12-21
DE60141181D1 (de) 2010-03-11

Similar Documents

Publication Publication Date Title
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
ITTO20010108A0 (it) Maschera facciale per subacquei.
BR0211690A (pt) Composição de glifosato e método de fabricação da mesma
NO20015477L (no) 4,5,6,7-tetrahydroindazolderivater som antitumormidler
BR0307924A (pt) N-aril-2-oxazolidinona-5-carboxamidas e seus derivados
DE60216854D1 (de) Polyamid-Zusammensetzung
DK1397366T3 (da) Hidtil ukendt ligander for nicotinacetylcholinreceptorer egnede i terapi
NO20034620D0 (no) Pustemaske
BR0112375A (pt) Métodos de sìntese para aplidina e novos derivados antitumorais, métodos para fabrica-los e usá-los.
ES2187261B2 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
DK1322654T3 (da) Platinkomplekser som antitumormidler
DE60221689D1 (de) Sprühdüse für wiederbefeuchtungs-spritzvorrichtung
DK1278759T3 (da) Bis-(N,N'-bis-(2-halogenethyl)amino)phoshoramidater som antitumormidler
NO20014753L (no) C(10)-karbonatsubstituerte taxaner som antitumormidler
NO20030868D0 (no) N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid
BR0112600A (pt) Compostos calcilìticos
BR0206841A (pt) Modificação cristalina de um depsipeptìdeo cìclico com melhor eficácia
FR2845288B1 (fr) Composition, notamment cosmetique, comprenant une amine secondaire ou tertiaire carbonylee
DE10295446D2 (de) Narkosegerät
NO20014755L (no) C(7)-karbonatsubstituerte taxaner som antitumormidler
ATE410379T1 (de) Verpackungseinheit für absorbierende artikel
NO20031239L (no) 1-amino-alkylsykloheksaner som trypanocidale midler
DE60229599D1 (de) Bis(diphenylvinyl)arenverbindung
DK1177185T3 (da) 4,5,6,7-tetrahydroindazolderivater som antitumormidler
ITTO20010065V0 (it) Indumento a cuscini d'aria anti-urto.